Mariko Sasaki

Targeting the Vulnerability of Glutathione Metabolism in ARID1A-Deficient Cancers

Hideaki Ogiwara, Kazuaki Takahashi, Mariko Sasaki et al. · Cancer Cell · 2019 · 286 citations · Full text

Glutathione Metabolism, Medicine, Cancer Biology +3

Targeting p300 Addiction in <i>CBP</i> -Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of <i>MYC</i> Expression

Hideaki Ogiwara, Mariko Sasaki, Takafumi Mitachi et al. · Cancer Discovery · 2015 · 179 citations · Full text

Neutrophil extracellular trap components in fibrinoid necrosis of the kidney with myeloperoxidase-ANCA-associated vasculitis

M. Yoshida, Mariko Sasaki, Kota Sugisaki et al. · Clinical Kidney Journal · 2013 · 70 citations · Full text

Glomerular Disease, Vasculitis, Myeloperoxidase-anca-associated Vasculitis +21

Therapeutic preferability of gemcitabine for ARID1A-deficient ovarian clear cell carcinoma

Takafumi Kuroda, Hideaki Ogiwara, Mariko Sasaki et al. · Gynecologic Oncology · 2019 · 33 citations · Full text

Efficacy of glutathione inhibitors for the treatment of ARID1A-deficient diffuse-type gastric cancers

Mariko Sasaki, Fumiko Chiwaki, Takafumi Kuroda et al. · Biochemical and Biophysical Research Communications · 2019 · 23 citations

Oncology, Gastrointestinal Oncology, Medicine +9